VPS34

Unknown Manufacturer

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Bi-heteroaryl compounds as Vps34 inhibitors
US 8685993 B2Applicant: TARACIDO IVAN CORNELLAPriority: 2011
CN
US
5 publications
COMBINATION THERAPY OF VPS34 INHIBITORS AND STING AGONIST FOR USE IN THE TREATMENT OF CANCER
EP 4384180 A1Applicant: DECIPHERA PHARMACEUTICALS LLCPriority: 2021
EP
US
WO
3 publications
HETEROARYLS AND USES THEREOF
- US 2013165483 A1
  Applicant: MILLENNIUM PHARM INCPriority: 2012
  US
  3 publications
- US 8859768 B2
  Applicant: CULLIS COURTNEY APriority: 2011
  US
  2 publications
Morpholine derivates as inhibitors of Vps34
US 11236079 B2Applicant: NEUROPORE THERAPIES INCPriority: 2018
CN
US
2 publications
Anti-viral activity of VPS34 inhibitors
- US 12414955 B2
  Applicant: DECIPHERA PHARMACEUTICALS LLCPriority: 2020
  CN
  US
  2 publications
- US 11801238 B2
  Applicant: DECIPHERA PHARMACEUTICALS LLCPriority: 2020
  CN
  US
  2 publications
VPS34 INHIBITORS AND METHODS OF USE THEREOF
US 20250236609 A1Applicant: DECIPHERA PHARMACEUTICALS LLCPriority: 2023
US
WO
2 publications
Macrocyclic pyrimidine derivatives
CN 114213415 AApplicant: ZHAN SEN PHARMACOLOGICAL CO LTDPriority: 2014
CN
2 publications
Methods for improving secondary metabolite production of fungi
US 2006263864 A1Applicant: BUSBY ROBERTPriority: 2002
US
NOVEL AUTOGRAPHY REGULATORS ATG14L AND RUBICON
US 2012041175 A1Applicant: YUE ZHENYUPriority: 2011
US
杂芳基化合物和其用途
CN 105916503 BApplicant: 米伦纽姆医药公司Priority: 2014
CN